ImmunosuppressantsCOVID-19, Cytomegalovirus reactivation and Pseudomonas infection: 4 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1887卷 / 1期

关键词：

D O I：

10.1007/s40278-022-08044-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：379 / 380

页数：1

相关论文

共 50 条

[31] ImmunosuppressantsCOVID-19 pneumonia: case report
Reactions Weekly, 2021, 1837 (1) : 340 - 340
[32] ImmunosuppressantsCOVID-19 reinfection: case report
Reactions Weekly, 2021, 1868 (1) : 216 - 216
[33] Antivirals/immunosuppressantsCOVID-19 infection and off label use: case report
Reactions Weekly, 2020, 1815 (1) : 52 - 52
[34] ImmunosuppressantsCOVID-19 infection, myelosuppression and febrile neutropenia: case report.
Reactions Weekly, 2020, 1814 (1) : 177 - 177
[35] Antibacterials/antivirals/immunosuppressantsCOVID-19 infection, COVID-19 pneumonia and off-label use: 7 case reports
Reactions Weekly, 2022, 1889 (1) : 38 - 38
[36] AzathioprineHuman cytomegalovirus reactivation and congenital human cytomegalovirus infection: 4 case reports
Reactions Weekly, 2020, 1822 (1) : 66 - 66
[37] ImmunosuppressantsCovid-19 pneumonia and delayed viral clearance: case report
Reactions Weekly, 2021, 1846 (1) : 172 - 172
[38] ImmunosuppressantsCOVID-19 pneumonia and Plasmodium vivax malaria: case report
Reactions Weekly, 2021, 1861 (1) : 164 - 164
[39] Immunosuppressant drugsMycobacterium haemophilum and cytomegalovirus infection reactivation: 2 case reports
Reactions Weekly, 2023, 1981 (1) : 205 - 205
[40] ImmunosuppressantsCOVID-2019 infection: 13 case reports
Reactions Weekly, 2020, 1834 (1) : 133 - 133

← 1 2 3 4 5 →